Locally Advanced or Metastatic ER+ HER2- Breast Cancer
1 clinical trials · Condition
◉ Watch Locally Advanced or Metastatic ER+ HER2- Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Study of PF-07248144 in Advanced or Metastatic Solid Tumors (NCT04606446) | Pfizer | 2020-11-16 |
Track Locally Advanced or Metastatic ER+ HER2- Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.